It was reported that in organ transplant receptors in vivo, the expression of TGF-β is associated with graft versus host disease (GVHD) and following transplantation, the patients with highly expressed TGF-β, exhibited significantly reduced GVHD (17). This evidence concerns the gene TGFB1 and graft versus host disease.